Atossa Therapeutics
ATOS
#10737
Rank
NZ$38.09 M
Marketcap
NZ$3.82
Share price
0.47%
Change (1 day)
156.45%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: NZ$38.09 Million

As of November 2026 Atossa Therapeutics has a market cap of NZ$38.09 Million. This makes Atossa Therapeutics the world's 10737th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$38.09 M-74.08%
2025NZ$0.14 B-32.85%
2024NZ$0.21 B25.51%
2023NZ$0.17 B65.42%
2022NZ$0.10 B-64.46%
2021NZ$0.29 B373.79%
2020NZ$62.6 M194.11%
2019NZ$21.28 M139.42%
2018NZ$8.89 M-24.56%
2017NZ$11.78 M52.84%
2016NZ$7.71 M-49.5%
2015NZ$15.26 M-65.94%
2014NZ$44.83 M-14.51%
2013NZ$52.43 M-14.38%
2012NZ$61.24 M

End of Day market cap according to different sources

On Nov 10th, 2026 the market cap of Atossa Therapeutics was reported to be:

NZ$38.09 Million
by Nasdaq info icon info icon
NZ$38.09 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.205 T 3,164,978.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$50.87 B 133,470.40%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$53.71 B 140,918.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$5.03 B 13,123.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$3.91 B 10,175.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$65.25 M 71.33%๐Ÿ‡บ๐Ÿ‡ธ USA